GI Dynamics rebrands as Morphic Medical and reintroduces RESET, formerly the EndoBarrier
GI Dynamics, the creator of the EndoBarrier device designed to target the underlying cause of type 2 diabetes, has announced it has...
GI Dynamics rebrands as Morphic Medical and reintroduces RESET, formerly the EndoBarrier
SADI-S superior as a revisional option for weight recurrence after SG compared to the OAGB-MGB
Journal Watch 05/07/2023
ASA’s Task Force: Stop taking GLP-1 medications for diabetes and weight loss before elective surgery
Phenomix Sciences launches MyPhenome Hungry Brain phenotype swab test
Should obesity be renamed to improve treatment and prevention?
Positive results for mizagliflozin in post-bariatric hypoglyceamia patients